Latest News and Events
Filter by
Selections
March 31, 2023
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Read MoreMarch 3, 2023
Arrowhead Pharmaceuticals to Present at 43rd Annual Cowen Health Care Conference
Read MoreFebruary 28, 2023
Arrowhead Announces Interim Results from Ongoing Phase 1/2 Study of ARO-C3 for Treatment of Complement Mediated Diseases
Read MoreFebruary 15, 2023
Arrowhead Pharmaceuticals Gains Full Rights to NASH Candidate ARO-PNPLA3 with Promising Phase 1 Results
Read MoreFebruary 2, 2023